Polyp Recurrence After Colonoscopic Polypectomy

Polyp Recurrence After Colonoscopic Polypectomy: What Chinese Patients and Doctors Need to Know

Colorectal cancer (CRC) is the third most common cancer worldwide, and its incidence and mortality are rising sharply in China—where it now ranks among the top threats to public health. The good news? Most CRCs start as polyps—precancerous growths that can be detected and removed via colonoscopy, a procedure that cuts CRC risk by preventing these lesions from turning malignant. The bad news? After polypectomy (polyp removal), there’s confusion about how soon patients need a follow-up colonoscopy. International guidelines (like those from the U.S. Multi-Society Task Force, or US MSTF) recommend 3–10 years based on a patient’s risk. But China has no national guidelines yet. Many doctors here default to a 1-year wait—but is that always necessary?

A 2020 study from Peking Union Medical College Hospital (PUMCH)—one of China’s top medical centers—sought to answer that question. Led by researchers from PUMCH’s Department of Gastroenterology (Qi-Pu Wang, Xu-Xia He, Jing-Nan Li) and colleagues from the Chinese Academy of Medical Sciences and Chongqing University Cancer Hospital, the study analyzed data from over 1,300 patients to identify risk factors for polyp recurrence and predict how soon new polyps might form.

What the Study Did

The team conducted a retrospective cohort study of patients who had at least two colonoscopies at PUMCH between 2012 and 2017. To be included, patients had to have at least one polyp in any colonoscopy, with a 6-month gap between procedures. They excluded people with a history of CRC, inflammatory bowel disease (like Crohn’s), or intestinal infections—since these conditions can affect polyp growth.

The researchers focused on three key factors from the baseline colonoscopy (the first one where polyps were removed):

  1. Polyp size: Tiny (0–5mm), small (6–10mm), or large (>10mm).
  2. Polyp number: Few (0–2), moderate (3–10), or many (>10).
  3. Polyp histology: Low-risk (hyperplastic polyps, tubular adenomas) or high-risk (tubulovillous/villous adenomas, serrated adenomas, polyps with dysplasia—abnormal cell growth).

They tracked how long it took for polyps to recur (come back) after the initial removal. Statistical tools like Kaplan-Meier analysis (to compare recurrence rates) and Cox regression (to find risk factors) helped them parse the data.

What They Found

After excluding ineligible patients, the study included 1,397 people (average age 58.6, 63% male). Here are the key results:

1. Recurrence Rates Vary by Risk

Over an average 2.5-year follow-up:

  • 26.9% of patients had recurrence within 6–12 months.
  • 36.7% had recurrence within 1–2 years.
  • 18.2% had recurrence within 2–3 years.
  • 12.2% had recurrence after 3 years.
  • Just 6% had no recurrence after 3 years.

2. Three Factors Predict Faster Recurrence

The team found that polyp size, number, and histology were the strongest predictors of how soon new polyps would form. Using hazard ratios (HR)—a measure of how much more likely one group is to experience an event (like recurrence)—they found:

  • Size: Patients with small polyps (6–10mm) were 1.39 times more likely to have recurrence than those with tiny polyps (0–5mm). Those with large polyps (>10mm) were 1.65 times more likely.
  • Number: People with moderate polyps (3–10) were 1.4 times more likely to have recurrence than those with few (0–2). Those with many polyps (>10) were 2.56 times more likely.
  • Histology: High-risk polyps (e.g., villous adenomas) led to a 1.51 times higher risk of recurrence compared to patients with no polyps at baseline. Low-risk polyps (e.g., hyperplastic polyps) still raised risk by 1.25 times.

3. Predicted Recurrence Times

Using linear regression, the team estimated how long patients might wait before new polyps form:

  • Low risk: 20–27 months (for 2 or fewer tiny polyps, or low-risk histology).
  • Moderate risk: 15–18 months (for 3–10 small polyps, or high-risk histology).
  • High risk: 13 months (for more than 10 polyps).

What This Means for Patients and Doctors

The study’s findings align with international guidelines—like the 2020 US MSTF update, which recommends 1-year follow-up for patients with over 10 adenomas. But they also highlight a critical gap in China: most doctors currently use a 1-year interval for everyone, even low-risk patients.

Here’s the takeaway:

  • High-risk patients (over 10 polyps): Stick to 1-year follow-up (matches global advice).
  • Moderate-risk patients (3–10 small/high-risk polyps): Consider 15–18 months—shorter than international guidelines (3–5 years) but justified because the study counted all polyps (not just advanced ones) as recurrence.
  • Low-risk patients (2 or fewer tiny/low-risk polyps): Wait 20–27 months—no need for a 1-year colonoscopy.

Why does this matter? Unnecessary colonoscopies mean more costs, discomfort, and risk (like bleeding or perforation) for patients. The study is a key step toward creating evidence-based guidelines for China, where CRC rates are rising and prevention is urgent.

Limitations to Keep in Mind

The study isn’t perfect:

  • It’s a single-center study, so results may not apply to all Chinese patients (e.g., those in rural areas with less access to advanced care).
  • Follow-up was short (average 2.5 years), so long-term recurrence (beyond 3 years) isn’t fully captured.
  • Recurrence time was measured as the gap between colonoscopies—not the actual time polyps took to grow. This means the numbers might be slightly inflated.

The Bottom Line

For Chinese patients who’ve had polyps removed, the wait for a follow-up colonoscopy shouldn’t be one-size-fits-all. This study gives doctors data to tailor surveillance: high-risk patients need faster follow-up, while low-risk patients can wait longer. As CRC rates rise in China, this kind of personalized care could save lives—and reduce unnecessary procedures.

Original Study Citation: Wang QP, He XX, Xu T, et al. Polyp recurrence after colonoscopic polypectomy. Chinese Medical Journal 2020;133(17):2114–2115. doi:10.1097/CM9.0000000000000990
For the full study, visit doi.org/10.1097/CM9.0000000000000990

Was this helpful?

0 / 0